Close
SmartTarget device for the detection of prostate cancer
The CE certified SmartTarget system is an image fusion device for guiding targeted, transperineal prostate biopsy. Designed and developed by biomedical engineers at UCL and urologists at NHS Trust hospital University College London Hospital (UCLH), the technology enables image-directed tumour targeting during minimally invasive biopsy procedures for prostate cancer patients and has undergone extensive clinical evaluation in over 200 patients at UCLH. To read more, visit their website.